INTEGRATED REPORT 2019
Consolidated statement of changes in equity
FOR THE YEAR ENDED 30 SEPTEMBER 2019
| Attributable to equity holders of the Company | |||||||||
| Notes | Stated capital R’m |
Other reserves R’m |
Distri- butable reserves R’m |
Retained earnings R’m |
Reserves R’m |
Non- control- ling interest R’m |
Total equity R’m |
||
| Balance at 1 October 2018 (as previously reported) | 13 510 | (189) | 26 | 1 569 | 1 406 | 1 286 | 16 202 | ||
|---|---|---|---|---|---|---|---|---|---|
| Transition adjustment relating to IFRS 9 | – | – | – | 20 | 20 | – | 20 | ||
| Balance at 1 October 2018 (restated) | 13 510 | (189) | 26 | 1 589 | 1 426 | 1 286 | 16 222 | ||
| Total comprehensive income for the year | – | 53 | – | 2 569 | 2 622 | 312 | 2 934 | ||
| Profit for the year | – | – | – | 2 569 | 2 569 | 302 | 2 871 | ||
| Other comprehensive income | – | 53 | – | – | 53 | 10 | 63 | ||
| Transactions with non-controlling interests | 26 | – | (60) | – | – | (60) | (44) | (104) | |
| Disposal of subsidiary | – | (5) | – | – | (5) | (18) | (23) | ||
| Distributions to shareholders | – | – | – | (1 321) | (1 321) | (233) | (1 554) | ||
| Purchase of treasury shares for staff benefit schemes | (72) | – | – | – | – | – | (72) | ||
| Vesting of treasury shares for staff benefit schemes | 75 | (65) | – | – | (65) | – | 10 | ||
| Disposal of treasury shares (exercised and forfeited) | 2 | (2) | – | – | (2) | – | – | ||
| Loss on disposal of treasury shares | – | – | (3) | – | (3) | – | (3) | ||
| Long-term incentive scheme charge | – | 23 | – | – | 23 | – | 23 | ||
| Life Healthcare employee share trust charge | – | 58 | – | – | 58 | – | 58 | ||
| Balance at 30 September 2019 | 13 515 | (187) | 23 | 2 837 | 2 673 | 1 303 | 17 491 | ||
| Note | 20 | ||||||||
| Balance at 1 October 2017 | 13 084 | 68 | 26 | 1 202 | 1 296 | 1 171 | 15 551 | ||
| Total comprehensive income for the year | – | 182 | – | 1 575 | 1 757 | 340 | 2 097 | ||
| Profit for the year | – | – | – | 1 575 | 1 575 | 339 | 1 914 | ||
| Other comprehensive income | – | 182 | – | – | 182 | 1 | 183 | ||
| Issue of new shares as a result of scrip distributions | 450 | – | – | – | – | – | 450 | ||
| Transactions with non-controlling interests | 26 | – | (474) | – | – | (474) | 19 | (455) | |
| Distributions to shareholders | – | – | – | (1 208) | (1 208) | (244) | (1 452) | ||
| Purchase of treasury shares for staff benefit schemes | (72) | – | – | – | – | – | (72) | ||
| Vesting of treasury shares for staff benefit schemes | 46 | (40) | – | – | (40) | – | 6 | ||
| Disposal of treasury shares (exercised and forfeited) | 2 | (2) | – | – | (2) | – | – | ||
| Long-term incentive scheme charge | – | 29 | – | – | 29 | – | 29 | ||
| Life Healthcare employee share trust charge | – | 48 | – | – | 48 | – | 48 | ||
| Balance at 30 September 2018 | 13 510 | (189) | 26 | 1 569 | 1 406 | 1 286 | 16 202 | ||
| Note | 20 |
The accompanying notes are an integral part of these consolidated financial statements.